Literature DB >> 12940774

Identification of poorly differentiated synovial sarcoma: a comparison of clinicopathological and cytogenetic features with those of typical synovial sarcoma.

M V C de Silva1, A D McMahon, L Paterson, R Reid.   

Abstract

AIMS: Poorly differentiated areas in synovial sarcomas (SS) are known to be associated with a poorer prognosis. The aim of our study was to describe the morphological spectrum of poorly differentiated synovial sarcomas (PDSS) and refine the criteria for their recognition. METHODS AND
RESULTS: The clinicopathological features of 28 PDSS were compared with those of 26 classic SS. Common cell types in PDSS included epithelioid, spindle and Ewing sarcoma-like small round cells. Unusual features included presence of desmoplastic small cell tumour-like areas and extraskeletal myxoid chondrosarcoma-like areas. The presence of necrosis (P = 0.002), a mitotic rate over 10/10 high-power fields (P < 0.001), a haemangiopericytomatous vascular pattern (P < 0.001) and vascular invasion (P = 0.003) were significantly associated with PDSS, while mast cells (P < 0.001), calcification (P < 0.001) and hyaline bands (P < 0.001) were significantly associated with classic SS. Poorly differentiated areas showed increased proliferative activity with Ki67. PDSS showed a tendency to be larger (P = 0.008) and to be located in proximal more than distal sites (P = 0.025). Three entirely poorly differentiated tumours were diagnosed by demonstration of the t(X;18)(p11;q11) translocation. PDSS showed additional cytogenetic abnormalities.
CONCLUSIONS: Poorly differentiated synovial sarcomas show a spectrum of histological features, which may simulate other malignant neoplasms. The diagnosis of entirely poorly differentiated synovial sarcomas requires cytogenetic analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12940774     DOI: 10.1046/j.1365-2559.2003.01668.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

Review 1.  Molecular and clinicopathological findings in a tonsillar synovial sarcoma. A case study and review of the literature.

Authors:  U Vogel; M Wehrmann; W Eichhorn; B Bültmann; M Stiegler; W Wagner
Journal:  Head Neck Pathol       Date:  2010-07-13

2.  BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall.

Authors:  Yu-Chien Kao; Yun-Shao Sung; Lei Zhang; Samuel Kenan; Samuel Singer; William D Tap; David Swanson; Brendan C Dickson; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2017-01-04       Impact factor: 5.006

3.  The value of multidisciplinary team (MDT) management in the diagnosis and treatment of primary intrathoracic synovial sarcomas: a single-center experience.

Authors:  Huayu He; Lin Yang; Yue Peng; Li Liu; Lei Liu; Qi Xue; Shugeng Gao
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

4.  Biphasic synovial sarcoma with a striking morphological divergence from the main mass to lymph node metastasis: A case report.

Authors:  Ha Young Woo
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

Review 5.  Primary mediastinal synovial sarcomas.

Authors:  Katherine Syred; Annikka Weissferdt
Journal:  Mediastinum       Date:  2020-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.